WO2020254606A1
|
|
Conjugates of heteroaromatic nitrogen-comprising compounds
|
WO2020254602A1
|
|
Conjugates of an electron-donating nitrogen or tertiary amine comprising compounds
|
WO2020254603A1
|
|
CONJUGATES OF π-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS
|
TW202042844A
|
|
Conjugates of pattern recognition receptor agonists
|
WO2020141222A1
|
|
Sustained local drug levels for innate immune agonists
|
WO2020141225A1
|
|
Minimization of systemic inflammation
|
WO2020141223A1
|
|
Induction of sustained local inflammation
|
AU2019345987A1
|
|
Novel hydrogel conjugates
|
AU2019350376A1
|
|
Treatment of infections
|
AU2019348440A1
|
|
Degradable hyaluronic acid hydrogels
|
AU2019246390A1
|
|
Conjugates
|
CN110809484A
|
|
Autoinjector with reconstitution handling support
|
CN110769873A
|
|
Autoinjector with variable plunger force
|
BR112019019658A2
|
|
conjugates, pharmaceutical compositions, method for treating an eye indication and method for producing a hydrogel drug conjugate
|
AU2017295938A1
|
|
Conjugation method for carrier-linked prodrugs
|
WO2017114910A1
|
|
Auto injector with adaptable air-shot mechanism
|
EP3397322A1
|
|
Auto injector with detection of used cartridge and associated method
|
AU2016383027A1
|
|
Auto injector with charger safety
|
AU2016383021A1
|
|
Auto injector with cartridge locking system
|
AU2016383023A1
|
|
Auto injector with temperature control
|